# AtriCure, Inc. (ATRC)

> AtriCure, Inc. (ATRC) trades at $55.02 (-0.52%) as of 7:31:45 PM EST on Nov 17, 2026, -0.92% over the past month. Market cap is $2.82B, with 7.6 days to cover in short interest.

Canonical: https://massive.com/quote/atrc
Data as of: 2026-11-18T00:31:45.029Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$55.02** -0.29 (-0.52%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$53.95** -1.07 (-1.94%)
As of 7:31:45 PM EST on Nov 17, 2026 · After hours

## Stock performance

How AtriCure, Inc. (ATRC) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -0.52% |
| 1W | -2.20% |
| 1M | -0.92% |
| YTD | +39.08% |
| 1Y | +65.92% |
| 52-wk range | $25.36 – $66.02 |

From daily closes through Nov 17, 2026.

## Key statistics

Today's trading snapshot for ATRC: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $53.88 – $55.98 |
| Open | $55.32 |
| Prev close | $55.31 |
| Volume | 663.59K |
| Market cap | $2.82B |
| Shares out | 50.92M |

## Valuation and profitability ratios

Valuation and profitability ratios for AtriCure, Inc.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | 189.24 |
| P/S | 4.78 |
| P/B | 5.28 |
| P/FCF | 53.20 |
| ROE | 2.8% |
| ROA | 2.1% |
| Debt/Equity | 0.11 |
| Div yield | 0.00% |

As of Nov 16, 2026

## Insider trading

[AtriCure, Inc. (ATRC) insider trading](https://massive.com/quote/atrc/insider-trading.md): open-market Form 4 buys and sells by AtriCure, Inc. insiders over the last 12 months.

## 8-K filings

Material corporate events AtriCure, Inc. has disclosed to the SEC on Form 8-K.

- Nov 3, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 3, 2026, AtriCure, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2026.”
- May 19, 2026 · Annual meeting results
  “The stockholders of the Company voted on the following proposals at the Annual Meeting: 1. The election of nine directors to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders... All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
- Jan 12, 2026 · Credit facility
  “On January 9, 2026, AtriCure, Inc. and its wholly owned subsidiary, AtriCure, LLC, entered into a First Amendment to Credit Agreement among the Borrowers, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto. The First Amendment provides for a three year extension of the term of the Credit Agreement. The First Amendment also provides for a reduction in the overall interest rate on the loans under the ABL Facility and removes the minimum utilization financial covenant in addition to certain other loan administration updates.”
- May 20, 2025 · Annual meeting results
  “The stockholders of the Company voted on the following proposals at the Annual Meeting: 1. The election of nine directors to serve one-year terms expiring at the 2026 Annual Meeting of Stockholders... Each nominee for director was duty elected to serve one-year terms expiring at the 2026 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
- Mar 26, 2025 · Investor presentation
  “On March 26, 2025, AtriCure, Inc. (the "Company") is conducting its previously announced 2025 Investor Day presentation from approximately 1:00 p.m. to 4:00 p.m. Eastern Time, at the Company's headquarters in Mason, Ohio which was simultaneously broadcast via webcast. A copy of the 2025 Investor Day presentation is furnished as Exhibit 99.1 to this Form 8-K.”

## ATRC short interest

How heavily ATRC is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 7.6 |
| Short interest | 4.89M |
| Avg volume | 643.49K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## ATRC news

The latest news and headlines about AtriCure, Inc. (ATRC).

- [Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 \| Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic](https://www.globenewswire.com/news-release/2026/08/26/3351252/28124/en/atrial-fibrillation-treatment-devices-market-trends-and-forecast-2035-includes-profiles-of-abbott-atricure-boston-scientific-johnson-johnson-and-medtronic.html) · GlobeNewswire Inc. · Aug 26, 2026 · positive sentiment
- [Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors](https://www.fool.com/coverage/filings/2026/08/07/two-atricure-directors-trimmed-shares-after-a-strong-quarter-here-s-what-matters-for-investors/?source=iedfolrf0000001) · The Motley Fool · Aug 7, 2026 · positive sentiment
- [Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?](https://www.fool.com/coverage/filings/2025/11/29/is-atricure-stock-a-buy-or-sell-after-a-director-dumped-10-000-shares/?source=iedfolrf0000001) · The Motley Fool · Nov 29, 2025 · neutral sentiment
- [Questex’s Fierce Healthcare Announces 2025 Fierce DEI Award Finalists](https://www.globenewswire.com/news-release/2025/05/14/3081465/0/en/Questex-s-Fierce-Healthcare-Announces-2025-Fierce-DEI-Award-Finalists.html) · GlobeNewswire Inc. · May 14, 2025 · positive sentiment
- [AtriCure gains China's nod for heart surgery device - Investing.com](https://www.investing.com/news/company-news/atricure-gains-chinas-nod-for-heart-surgery-device-93CH-3531753) · Investing.com · Jul 23, 2024 · positive sentiment

## About AtriCure, Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 1.35K |
| Listed | Aug 5, 2005 |

[Company website](https://www.atricure.com)

## FAQ

### What is the AtriCure, Inc. (ATRC) stock price today?

AtriCure, Inc. (ATRC) is trading at $55.02 (-0.52% on the day) as of 7:31:45 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is AtriCure, Inc.?

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors.

### What is the short interest in ATRC?

As of Oct 30, 2026, ATRC has 4.89M shares short and 7.6 days to cover.

### What exchange is ATRC listed on?

AtriCure, Inc. (ATRC) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

## Live data

Prices here are 15-minute delayed. For real-time ATRC quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=ATRC`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [AtriCure, Inc. (ATRC) insider trading](https://massive.com/quote/atrc/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
